Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study

BACKGROUND: Systemic therapy options for salivary cancers are limited. MyPathway (NCT02091141), a phase IIa study, evaluates targeted therapies in non-indicated tumor types with actionable molecular alterations. Here, we present the efficacy and safety results for a subgroup of MyPathway patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurzrock, R., Bowles, D. W., Kang, H., Meric-Bernstam, F., Hainsworth, J., Spigel, D. R., Bose, R., Burris, H., Sweeney, C. J., Beattie, M. S., Blotner, S., Schulze, K., Cuchelkar, V., Swanton, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743163/
https://www.ncbi.nlm.nih.gov/pubmed/32067683
http://dx.doi.org/10.1016/j.annonc.2019.11.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743163/
https://www.ncbi.nlm.nih.gov/pubmed/32067683
http://dx.doi.org/10.1016/j.annonc.2019.11.018

Ejemplares similares